Understandably, there is a huge interest in glucagon-like peptide-1 (GLP-1) receptor agonists among patients, medical professionals, and the general public. These medications produce greater weight loss in a high proportion of persons with obesity and overweight than any of the other available interventions. And, they seem to have a wide range of other benefits, both…